Neu auf wallstreet:online? Jetzt kostenlos registrieren!
Registrieren | Login
x
Benutzername:

Passwort:

Angemeldet bleiben
Passwort vergessen?

    DGAP-News Raptor Pharmaceutical Corp. to Present at Two Upcoming Investor Conferences

    Nachrichtenquelle: EQS Group AG
     |  03.05.2012, 12:30  |  89 Aufrufe  |   | 


    Raptor Pharmaceutical Corp.

    03.05.2012 12:30



    NOVATO, Calif., 2012-05-03 12:30 CEST (GLOBE NEWSWIRE) --
    Raptor Pharmaceutical Corp. (´Raptor´ or the ´Company´) (Nasdaq:RPTP), today
    announced that Christopher M. Starr, Ph.D., Chief Executive Officer of Raptor,
    will present an overview of the Company at two investor conferences in May.


    The conference presentation schedule is as follows:

    Deutsche Bank 37th Annual Healthcare Conference
    May 8, 2012 at 1:30pm ET                       
    InterContinental, Boston, MA                   

                                                            
    Bank of America Merrill Lynch 2012 Healthcare Conference
    May 16, 2012 at 10:00am PT                              
    Encore at the Wynn, Las Vegas, NV                       

    A live audio webcast and 14-day archive of the Bank of America presentation
    will be available at http://ir.raptorpharma.com/events.cfm

    About Raptor Pharmaceutical Corp.

    Raptor Pharmaceutical Corp. (Nasdaq:RPTP) (´Raptor´) seeks to research,
    produce, and deliver medicines that improve life for patients with severe, rare
    disorders. Raptor currently has product candidates in clinical development
    designed to potentially treat nephropathic cystinosis, Non-alcoholic
    Steatohepatitis (´NASH´), Huntington´s Disease (´HD´), aldehyde dehydrogenase
    deficiency (´ALDH2´), and thrombotic disorder.

    Raptor´s preclinical programs are based upon bioengineered novel drug
    candidates and drug-targeting platforms derived from the human
    receptor-associated protein and related proteins that are designed to target
    cancer and infectious diseases.

    For additional information, please visit www.raptorpharma.com.

    The Raptor Pharmaceutical Corp. logo is available at
    http://www.globenewswire.com/newsroom/prs/?pkgid=7180

             CONTACT: Trout Group (investors)
             Lauren Glaser
             (646) 378-2972
             lglaser@troutgroup.com
             
             EVC Group (media)
             Janine McCargo
             (646) 688-0425
             jmccargo@evcgroup.com
    News Source: NASDAQ OMX

    03.05.2012 Dissemination of a Corporate News, transmitted by DGAP -
    a company of EquityStory AG.
    The issuer is solely responsible for the content of this announcement.

    DGAP´s Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de




    Language:     English
    Company:      Raptor Pharmaceutical Corp.
                  
                   
                  United States
    Phone:        
    Fax:          
    E-mail:       
    Internet:     
    ISIN:         US75382F1066
    WKN:          

    End of Announcement                             DGAP News-Service





    Schreibe Deinen Kommentar

     

    Disclaimer

    Enthaltene Werte

    WertpapierKursZeitPerf. %
    9,81
    25.11.
    -1,11

    Nachrichtenquelle

    Weitere Nachrichten des Autors

    TitelLeser
    302
    227
    217
    193
    184
    TitelLeser
    458
    453
    432
    427
    371
    TitelLeser
    831
    803
    784
    770
    759
    TitelLeser
    12198
    11909
    8071
    7260
    6352

    Top Nachrichten aus der Rubrik